Mammographic screening and breast cancer mortality: A case-control study and meta-analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 9, 2012, Pages 1479-1488

  Nickson, Carolyn ^a   Mason, Kate E ^a   English, Dallas R ^a   Kavanagh, Anne M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CASE CONTROL STUDY; FEMALE; HEALTH PROGRAM; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED;

EID: 84866175279     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0468     Document Type: Article

References (64)

1. International Agency for Research on Breast Cancer. Breast cancer screening. Lyon, France: International Agency for Research on Breast Cancer; 2002.
2. US National Institutes of Health International Cancer Screening Network. Organization of Breast Cancer Screening Programs in 27 ICSN Countries, 2007-2008. 2011. [cited 2011 Feb 24]. Available from: http://appliedresearch. cancer.gov/icsn/breast/screening.html.
3. Coldman A, Phillips N. Population studies of the effectiveness of mammographic screening. Prev Med 2011;53:115-7.
4. Australian Institute of Health and Welfare. Breast cancer screening in Australia: future directions. Canberra, Australia: Australian Health Minister's Advisory Council: Breast Cancer Screening Evaluation Steering Committee; 1990.
5. Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008;108:409-16.
6. Taylor R, Morrell S, Estoesta J, Brassil A. Mammography screening and breast cancer mortality in New South Wales, Australia. Cancer Causes Control 2004;15:543-50.
7. National Breast and Ovarian Cancer Centre. Screening monograph No. 4/2009. BreastScreen Australia evaluation: Mortality (ecological) study. Canberra, Australia. Prepared for the Australian Government Department of Health and Ageing; May 2009.
8. Burton RC, Bell RJ, Thiagarajah G, Stevenson C. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat 2012;131:949-55.
9. Medew J. Women face trauma of over-zealous screening. Sydney Morning Herald. 2011 Nov 4; Sect. News and Features: 3.
10. Medew J. Breast cancer 'over-diagnosed'. The Age. 2011 Nov 4; Sect. News: 1.
11. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:d4411.
12. Smyth C. Cancer deaths fall 'not due to screening'. The Times (London). 2011 Jul 29; Sec. News: p26.
13. Bakalar N. Screening: Mammograms' Value Questioned in Europe. The New York Times. 2011 August 2; Sect. Science Desk: p6.
14. Hutchinson L. Screening: reduced breast cancer mortality rates in Europe are not due to screening. Nat Rev Clin Oncol 2011;8:1.
15. Morgan B. Breast screening impact not significant. ABC Science News in Science; 2011 Jul 29 [cited 2011 Dec 1]. Available from: http://www.abc.net.au/ science/articles/2011/07/29/3280414.htm.
16. Kalager M, Zelen M, Langmark F, Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010;363:1203-10.
17. Schopper D, de Wolf C. How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 2009;45:1916-23.
18. Haukka J, Byrnes G, Boniol M, Autier P. Trends in breast cancer mortality in Sweden before and after implementation of mammography screening. PLoS One 2011;6:e22422.
19. Paap E, Verbeek ALM, Puliti D, Paci E, Broeders MJM. Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol 2011;22:863-9.
20. Walter SD. Mammographic screening: case-control studies. Ann Oncol 2003;14:1190-2.
21. Australian Government Department of Health and Ageing. BreastScreen Australian Program. BreastScreen Australia Evaluation. [cited 2009 Feb 23]. Available from: http://www.cancerscreening.gov.au/internet/screening/publishing. nsf/Content/br-evaluation-lp
22. Australian Electoral Commission. Measuring the electoral rolls: a report on the results from the Sample Audit Fieldwork March 2005. Canberra, Australia: Australian Electoral Commision; 2005.
23. Kelman C, Bass A, Holman C. Research use of linked health data-a best practice protocol. Aust N Z Publ Health 2002;26:5.
24. Greenland S, Thomas DC. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982;116:547-53.
25. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35.
26. Friedman DR, Dubin N. Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol 1991;133:974-84.
27. Weiss NS, McKnight B, Stevens NG. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 1992;135:817-23.
28. Weiss NS. Application of the case-control method in the evaluation of screening. Epidemiol Rev 1994;16:102-8.
29. Australian Bureau of Statistics. 2901.0 - Census Dictionary, 2006 (Reissue). 2006 [cited 2011 20 Dec]. Available from: http://www.abs.gov.au/ Ausstats/abs@.nsf/0/413876F3BAE9CC70CA25720A000C428B
30. Australian Bureau of Statistics. 2039.0 - Information Paper: An Introduction to Socio-Economic Indexes for Areas (SEIFA), 2006. 2008 [cited 2011 20 Dec]. Available from: http://www.abs.gov.au/ausstats/abs@.nsf/mf/2039.0/
31. Commonwealth Department of Health and Aged Care. Measuring Remoteness: Accessibility/Remoteness Index of Australia (ARIA): Revised Edition. Occasional Papers: New Series Number 14. Canberra. October 2001.
32. Gabe R, Duffy SW. Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 2005;16:153-62.
33. Church TR. A novel form of ascertainment bias in case-control studies of cancer screening. J Clin Epidemiol 1999;52:837-47.
34. Allgood PC, Warwick J, Warren RML, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008;98:206-9.
35. Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 2004;11:194-8.
36. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 2007;48:948-55.
37. Greenland S, Lash TL. Bias analysis. In: Rothman KJ, Greenland S, Lash TL, editors. Modern Epidemiology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 348-51.
38. BreastScreen WA. BreastScreen WA 2000-2001 statistical report. Perth, Australia: BreastScreen WA; 2001.
39. Women's Health Australia. The Australian Longitudinal Study on Women's Health. Data Book for Survey 3 of the Mid-Age Cohort 2001 (50-55 years). Newcastle (Australia); March 2004.
40. Banks E, Beral V, Bull D, Reeves G, Austoker J, English R, et al. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
41. Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 2006;8:571-5.
42. Beral V, Bull D, Doll R, Peto R, Reeves G, Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease. Lancet 2001;358:1389-99.
43. Palli D, Del Turco MR, Buiatti E, Ciatto S, Crocetti E, Paci E. Time interval since last test in a breast cancer screening programme: a case-control study in Italy. J Epidemiol Community Health 1989;43:241-8.
44. Miltenburg GA, Peeters PH, Fracheboud J, Collette HJ. Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom. Br J Cancer 1998;78:962-5.
45. Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 2008;99:423-7.
46. van Schoor G, Moss SM, Otten JDM, Donders R, Paap E, den Heeten GJ, et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011;104:910-4.
47. Otto SJ, Fracheboud J, Verbeek AL, Boer R, Reijerink-Verheij JC, Otten JD, et al. Mammography screening and risk of breast cancer death: a population-based case-control Study. Cancer Epidemiol Biomarkers Prev 2012;21:66-73.
48. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557-60.
49. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
50. Demissie K, Mills OF, Rhoads GG. Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography. J Clin Epidemiol 1998;51:81-91.
51. Duffy SW, Cuzick J, Tabar L, Vitak B, Chen THH, Yen MF, et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J R Stat Soc Ser C-Appl Stat 2002;51:235-43.
52. International Cancer Screening Network. Organisation of Breast Cancer Screening Programs in 27 ICSN Countries, 2007-2008. 2011 [Updated 24 Feb 2011; cited 13 June 2012]. Available from: http://appliedresearch.cancer.gov/icsn/ breast/screening.html
53. Broeders MJ, Peer PG, Verbeek AL. Positive effects of breast cancer screening on mortality from breast cancer: 17 year DOM-project in Utrecht evaluated with a case control study. Ned Tijdschr Geneeskd 1999;143:698-9.
54. Tijmstra TJ. Efficacy of mass screening for breast cancer; reduction in mortality nationally and abroad. Ned Tijdschr Geneeskd 1991;135:242-3.
55. de Koning HJ. Screen evaluation without evaluating screening? (Rapid Response). British Medical Journal; 2011 Sep 12 [cited 2011 Dec 1]: [about 1 p.]. Available from: http://www.bmj.com/rapid-response/2011/11/03/screen- evaluation-without-evaluating-screening.
56. Allgood PC, Warwick J, Warren RML, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008;98:206-9.
57. Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 2004;11:194-8.
58. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiologica (Stockholm, Sweden: 1987) 2007;48:948-55.
59. Miltenburg GA, Peeters PH, Fracheboud J, Collette HJ. Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom. Br J Cancer 1998;78:962-5.
60. Palli D, Rosselli del Turco M, Buiatti E, Ciatto S, Crocetti E, Paci E. Time interval since last test in a breast cancer screening programme: a case-control study in Italy. J Epidemiol Community Health 1989;43:241-8.
61. Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 2008;99:423-7.
62. Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008;108:409-16.
63. van Schoor G, Moss SM, Otten JDM, Donders R, Paap E, den Heeten GJ, et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011;104:910-4.
64. Otto SJ, Fracheboud J, Verbeek ALM, Boer R, Reijerink-Verheij JCIY, Otten JDM, et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:66-73.